HomeCompareSULZF vs MRK

SULZF vs MRK: Dividend Comparison 2026

SULZF yields 2.46% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SULZF wins by $162.38M in total portfolio value· pulled ahead in Year 2
10 years
SULZF
SULZF
● Live price
2.46%
Share price
$209.03
Annual div
$5.15
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$162.44M
Annual income
$150,688,496.35
Full SULZF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — SULZF vs MRK

📍 SULZF pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSULZFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SULZF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SULZF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SULZF
Annual income on $10K today (after 15% tax)
$209.36/yr
After 10yr DRIP, annual income (after tax)
$128,085,221.90/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, SULZF beats the other by $128,076,625.18/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SULZF + MRK for your $10,000?

SULZF: 50%MRK: 50%
100% MRK50/50100% SULZF
Portfolio after 10yr
$81.25M
Annual income
$75,349,305.07/yr
Blended yield
92.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SULZF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
4.0
Piotroski
8/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SULZF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSULZFMRK
Forward yield2.46%2.81%
Annual dividend / share$5.15$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$162.44M$57.7K
Annual income after 10y$150,688,496.35$10,113.78
Total dividends collected$161.54M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: SULZF vs MRK ($10,000, DRIP)

YearSULZF PortfolioSULZF Income/yrMRK PortfolioMRK Income/yrGap
1$11,193$492.61$11,213$373.04$20.00MRK
2← crossover$13,007$1,030.58$12,667$512.06+$340.00SULZF
3$16,156$2,238.52$14,439$708.14+$1.7KSULZF
4$22,484$5,197.15$16,640$988.16+$5.8KSULZF
5$37,577$13,519.31$19,432$1,394.07+$18.1KSULZF
6$82,440$42,233.18$23,057$1,992.90+$59.4KSULZF
7$261,400$173,188.73$27,889$2,894.79+$233.5KSULZF
8$1,306,132$1,026,434.37$34,518$4,286.29+$1.27MSULZF
9$10,984,038$9,586,476.84$43,912$6,494.35+$10.94MSULZF
10$162,441,418$150,688,496.35$57,714$10,113.78+$162.38MSULZF

SULZF vs MRK: Complete Analysis 2026

SULZFStock

Sulzer Ltd provides fluid engineering services. The company operates through Flow Equipment, Services, Chemtech, and Others segments. It offers side-mounted horizontal and top-mounted vertical agitators, dynamic chemical mixers, and tower and tank flow management products; tower management systems; turbo compressors, aeration systems, and mechanical aerators; cartridges, mixers, dispensers, and accessories; process solutions, which include the initial concept and pilot testing; medium consistency products; pumping solutions and auxiliary equipment; and control and monitoring equipment. The company also provides lifting stations; pump and lifting station accessories; products for distillation, absorption, stripping, evaporation, phase separation, liquid-liquid extraction, and crystallization; static and submersible mixers; solids reduction, separation, and removal systems; and screening, sedimentation, and filtration solutions. In addition, its services include rotating equipment services; static equipment services, welding, plant maintenance, and turnaround project services. Further, the company digital solution, which includes control and monitoring software solutions that include a range of software primarily designed to simplify set-up and maintenance for web-based alarm handling and monitoring software; sense condition monitoring solutions, which detects possible equipment failures early on and optimizes maintenance planning.; PumpsOnline services that allow access to equipment-related information; BLUE BOX, a collaborative digital solution; and DOC BOX, which allows users to systematically identify the root cause of a problem. It serves oil and gas; chemical; general industry; water; power; adhesive, dental, and healthcare; and beauty markets. The company operates in Switzerland, the United Kingdom, Saudi Arabia, Germany, Spain, Sweden, the Americas, and the Asia Pacific. Sulzer Ltd was founded in 1834 and is headquartered in Winterthur, Switzerland.

Full SULZF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SULZF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SULZF vs SCHDSULZF vs JEPISULZF vs OSULZF vs KOSULZF vs MAINSULZF vs JNJSULZF vs ABBVSULZF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.